Daily oral estramustine and intermittent intravenous docetaxel (Taxotere) as chemotherapeutic treatment for metastatic, hormone-refractory prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/10604267

Download in:

View as

General Info

PMID
10604267